Event Title Go back to Home Page
Event Summary  
Event Type Medicine - Pharmaceutical Recalls  Date Time 2018-11-27 06:03:00 
Country US  City Washington D.C. 
Latitude 38.907  Longitude -77.037 
URL https://www.usrecallnews.com/teva-pharmaceuticals-usa-issues-voluntary-nationwide-recall-of-all-amlodipine-valsartan-combination-tablets-and-amlodipine-valsartan-hydrochlorothiazide-combination-tablets-that-are-within-expiry/     
Description  
[usrecallnews.com] DISTRICT OF COLUMBIA - Teva Pharmaceuticals USA Issues Voluntary Nationwide Recall Of All Amlodipine - Valsartan Combination Tablets And Amlodipine-Valsartan-Hydrochlorothiazide Combination Tablets That Are Within Expiry

"Teva Pharmaceuticals has initiated a voluntary recall in the United States, to the patient level, of all lots of Amlodipine / Valsartan combination tablets and Amlodipine / Valsartan / Hydrochlorothiazide combination tablets (see table below) due to an impurity detected above specification limits in an active pharmaceutical ingredient (API) manufactured by Mylan India."

Read the full article:

https://www.usrecallnews.com/teva-pharmaceuticals-usa-issues-voluntary-nationwide-recall-of-all-amlodipine-valsartan-combination-tablets-and-amlodipine-valsartan-hydrochlorothiazide-combination-tablets-that-are-within-expiry/ 

  Events

Copyright © 2006-2012  All Rights Reserved.